JP2011507858A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507858A5
JP2011507858A5 JP2010539514A JP2010539514A JP2011507858A5 JP 2011507858 A5 JP2011507858 A5 JP 2011507858A5 JP 2010539514 A JP2010539514 A JP 2010539514A JP 2010539514 A JP2010539514 A JP 2010539514A JP 2011507858 A5 JP2011507858 A5 JP 2011507858A5
Authority
JP
Japan
Prior art keywords
composition
connexin
polynucleotide
drug
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539514A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507858A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/014022 external-priority patent/WO2009085271A2/en
Publication of JP2011507858A publication Critical patent/JP2011507858A/ja
Publication of JP2011507858A5 publication Critical patent/JP2011507858A5/ja
Pending legal-status Critical Current

Links

JP2010539514A 2007-12-21 2008-12-22 整形外科状態の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた、抗コネキシンペプチドの使用 Pending JP2011507858A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US883407P 2007-12-21 2007-12-21
PCT/US2008/014022 WO2009085271A2 (en) 2007-12-21 2008-12-22 Use of anti-connexin peptides, alone or in combination with anti-connexin polynucleotides, for the treatment of orthopedic conditions

Publications (2)

Publication Number Publication Date
JP2011507858A JP2011507858A (ja) 2011-03-10
JP2011507858A5 true JP2011507858A5 (enExample) 2013-04-25

Family

ID=40824956

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010539514A Pending JP2011507858A (ja) 2007-12-21 2008-12-22 整形外科状態の治療のための、単独のまたは抗コネキシンポリヌクレオチドと組み合わせた、抗コネキシンペプチドの使用

Country Status (7)

Country Link
US (1) US20110243964A1 (enExample)
EP (1) EP2242844A2 (enExample)
JP (1) JP2011507858A (enExample)
AU (1) AU2008343842A1 (enExample)
CA (1) CA2710382A1 (enExample)
WO (1) WO2009085271A2 (enExample)
ZA (1) ZA201005218B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101573131B (zh) 2005-02-03 2017-12-01 科达治疗有限公司 抗‑连接蛋白化合物及其治疗应用
EA015304B1 (ru) 2006-08-03 2011-06-30 Нитек Фарма Аг Лечение ревматоидного заболевания глюкокортикоидами с отсроченным высвобождением
EP2245158A2 (en) * 2007-12-11 2010-11-03 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments
AU2008343840A1 (en) * 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions
WO2009085270A2 (en) 2007-12-21 2009-07-09 Coda Therapeutics, Inc. Use of inhibitors of c0nnexin43 for treatment of fibrotic conditions
CN102099475A (zh) * 2008-06-04 2011-06-15 科达治疗公司 用间隙连接调节化合物治疗疼痛
CN104271142B (zh) 2012-03-01 2017-07-04 福斯特斯特林研究公司 含有α连接蛋白C‑末端(ACT)肽的局部凝胶
WO2015027120A1 (en) 2013-08-21 2015-02-26 Jiang Jean X Compositions and methods for targeting connexin hemichannels
CA2958879A1 (en) 2014-08-22 2016-02-25 Auckland Uniservices Limited Channel modulators
CA3015839A1 (en) 2016-02-26 2017-08-31 The Board Of Regents Of The University Of Texas System Connexin (cx)43 hemichannel-binding antibodies and uses thereof
JP7495230B2 (ja) 2017-04-28 2024-06-04 オークランド ユニサービシズ リミテッド 処置方法および新規構築物
MX2023004631A (es) 2020-10-22 2023-07-20 Xequel Bio Inc Formulaciones peptidicas y usos oftalmicos de las mismas.
WO2025030173A1 (en) * 2023-08-03 2025-02-06 Next Science IP Holdings Pty Ltd Reducing inflammation in surgical site tissues

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2314321E (pt) * 1999-01-27 2014-09-26 Coda Therapeutics Inc Elemento de encaminhamento de um fluido de refrigeração de uma ferramenta de corte e processo para este encaminhamento
JP2003238441A (ja) * 2002-02-08 2003-08-27 英行 ▲高▼野 血管新生抑制剤
CA2536096A1 (en) * 2004-01-30 2005-08-18 Angiotech International Ag Compositions and methods for treating contracture
CN101573131B (zh) * 2005-02-03 2017-12-01 科达治疗有限公司 抗‑连接蛋白化合物及其治疗应用
US7767710B2 (en) * 2005-05-25 2010-08-03 Calosyn Pharma, Inc. Method for treating osteoarthritis
KR20150072458A (ko) * 2006-11-15 2015-06-29 코다 테라퓨틱스, 인크. 상처 치유를 위한 개선 방법 및 조성물
EP2245158A2 (en) * 2007-12-11 2010-11-03 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments

Similar Documents

Publication Publication Date Title
JP2011507858A5 (enExample)
JP2011507860A5 (enExample)
JP2011507861A5 (enExample)
JP2011506447A5 (enExample)
JP2011507855A5 (enExample)
Thiede et al. Pharmacokinetics of sustained-release and transdermal buprenorphine in Göttingen minipigs (Sus scrofa domestica)
JP2009544585A5 (enExample)
JP2005512976A5 (enExample)
CN109477109A (zh) 靶向人lmna的寡核苷酸类似物
JP2006515351A5 (enExample)
HUE029677T2 (hu) Készítmények centrálisan mediált émelygés és hányás kezelésére
JP2009519949A5 (enExample)
JP2011507859A5 (enExample)
CN107847565A (zh) 用于肌肉减少症治疗的包括胰高血糖素样肽‑1 受体激动剂的药物组合物
JP2024521091A (ja) 褐色脂肪生成を誘導する方法及び組成物
WO2009150214A3 (en) Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease
Bufalari et al. Preemptive carprofen for peri-operative analgesia in dogs undergoing Tibial Plateau Leveling Osteotomy (TPLO): a prospective, randomized, blinded, placebo controlled clinical trial
IL194500A (en) A peptide substance capable of increasing capillary resistance and pharmacological preparation containing the above
Chen et al. Systemic penicillin as an experimental model of epilepsy
CN112156104B (zh) 一种治疗抑郁症的药物
US20100105762A1 (en) Therapeutic agent for periodontal disease and alveolar bone loss due to surgery
CN114703157B (zh) 多肽及其用于治疗缺血性脑卒中的应用
Yadav et al. Efficacy of xylazine as a sedative in cattle
CN115381953B (zh) Zip1在抑制瑞芬太尼诱发的痛觉过敏中的应用
CN115252787B (zh) Zip7在抑制阿片类药物诱发的痛觉过敏中的应用